Real-World Therapeutic Hypothermia for Neonatal HIE: Neurodevelopmental Outcomes and Predictors
- PMID: 40533883
- DOI: 10.1111/apa.70186
Real-World Therapeutic Hypothermia for Neonatal HIE: Neurodevelopmental Outcomes and Predictors
Abstract
Aim: This study assessed neurodevelopmental outcomes in neonates with hypoxic-ischemic encephalopathy (HIE) treated with therapeutic hypothermia (TH) outside randomised controlled trials (RCTs). It also aimed to identify predictors of outcomes and evaluate TH practices across centres.
Methods: A prospective, area-based observational study was conducted in eight Italian NICUs (2016-2021), including neonates treated with TH for any grade of HIE. A 2-year neurodevelopmental follow-up was performed. Severe functional disability (SFD) was defined as cerebral palsy (Gross Motor Function Classification Level > 2), cognitive score < 2 SD, bilateral blindness/deafness, or epilepsy. Demographic, clinical and MRI data were analysed.
Results: Among 283 cooled infants, 11 (3.8%) died and 272 (96.2%) survived. HIE severity was mild (14.0%), moderate (76.1%) and severe (9.9%). Follow-up data were available for 232 (85.3%) survivors, with SFD diagnosed in 27 (11.6%). No infants with mild HIE developed SFD. Severe MRI anomalies were found in 51.9% of SFD cases, while 90.7% of non-SFD children had normal findings. cEEG/aEEG-confirmed seizures (OR = 12.9, CI 3.5-65.0) and severe MRI anomalies (OR = 0.24, CI 0.13-0.44) were strong SFD predictors (AUC = 0.95).
Conclusion: Mortality and SFD rates were lower than in RCTs. Seizures and severe MRI anomalies predicted poor outcomes. Further RCTs are needed to refine treatment criteria.
Keywords: brain MRI; brain cooling; cerebral palsy; hypoxic–ischemic encephalopathy; therapeutic hypothermia.
© 2025 The Author(s). Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.
References
-
- S. E. Jacobs, M. Berg, R. Hunt, W. O. Tarnow‐Mordi, T. E. Inder, and P. G. Davis, “Cooling for Newborns With Hypoxic Ischaemic Encephalopathy,” Cochrane Database of Systematic Reviews 2013 (2013): CD003311, https://doi.org/10.1002/14651858.CD003311.pub3.
-
- Committee on Fetus and Newborn, L. A. Papile, J. E. Baley, et al., “Hypothermia and Neonatal Encephalopathy,” Pediatrics 133 (2014): 1146–1150, https://doi.org/10.1542/peds.2014‐0899.
-
- J. Proietti, G. B. Boylan, and B. H. Walsh, “Regional Variability in Therapeutic Hypothermia Eligibility Criteria for Neonatal Hypoxic‐Ischemic Encephalopathy,” Pediatric Research 96 (2024): 1153–1161, https://doi.org/10.1038/s41390‐024‐03184‐6.
-
- I. R. Goswami, H. Whyte, P. Wintermark, et al., “Characteristics and Short‐Term Outcomes of Neonates With Mild Hypoxic‐Ischemic Encephalopathy Treated With Hypothermia,” Journal of Perinatology: Official Journal of the California Perinatal Association 40 (2020): 275–283, https://doi.org/10.1038/s41372‐019‐0551‐2.
-
- B. Kracer, S. R. Hintz, K. P. Van Meurs, and H. C. Lee, “Hypothermia Therapy for Neonatal Hypoxic Ischemic Encephalopathy in the State of California,” Journal of Pediatrics 165 (2014): 267–273, https://doi.org/10.1016/j.jpeds.2014.04.052.
Grants and funding
LinkOut - more resources
Full Text Sources